News
The technology proved its merit in a pilot that reported high detection rates and adherence, and is already in use at 15 VA medical centers.
The startup develops non-invasive blood tests that achieve early cancer detection and improve treatment selection.
Representatives from cardio monitoring device maker Eko and the FDA offer advice for medical device startups gearing up for their first approval.
BlueCross BlueShield Venture Partners led the round with participation from Threshold Ventures, F-Prime Capital and Wellframe's existing clients.
The new tool will also be localized to provide relevant medical information.
CEO Adrian Gilmore said the company is looking at strategic partnerships, M&A and other general scaling of the business in the year to come.
Deloitte is also working with Amgen to create a tool specifically designed to support patients in new therapies.
The VentureConnect series will include a Startup Showcase at the JP Morgan Healthcare Conference in San Francisco and a Startup Pitch Competition at the HIMSS20 Global Conference in Orlando.
The company plans to use the funding to expand its capabilities to identify more conditions incuding schizophrenia and multiple sclerosis.